TRPV1 and Parkinson disease: Taken together, our data carefully suggest that AEA synthesized by CAP-activated TRPV1 appears to inhibit glial activation-derived neuroinflammation and the resultant survival of dopamine neurons in the MPTP mouse model of PD, although we did not provide any direct evidence of AEA synthesis by CAP-activated TRPV1.